BeStock  
Stocks › Gene Editing › BEAM

Beam Therapeutics BEAM

US equityMarket cap rank #2634AI medical concept stocksGene Editing
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–

BEAM Stock News

Headlines matching Beam Therapeutics or the BEAM ticker, most recent first.

  • JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35Market news · 9 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $35 to $80Market news · 9 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $80Market news · 9 Sep 2026 · Direct mention
  • Shimizu has added a 1.5-hour fire-resistant specification to its Hi-Wood Beam product lineup.Shimizu · 3 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Announces Target Price $44Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $43 to $78Market news · 6 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $35 to $78Market news · 5 Aug 2026 · Direct mention
  • Freedom Capital Markets Downgrades Beam Global(BEEM.US) to Hold Rating, Maintains Target Price $1.5 NegativeMarket news · 26 Aug 2026 · Direct mention
  • Maxim Group Maintains Beam Global(BEEM.US) With Buy Rating, Cuts Target Price to $3 NegativeMarket news · 22 Aug 2026 · Direct mention
  • BofA Securities Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $47Market news · 9 Jul 2026 · Direct mention
  • HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price TargetBenzinga · 7 Jul 2026 · Direct mention
  • 4: Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Evans John M.SEC · 2 Jul 2026 · Direct mention
  • Freedom Capital Markets Initiates Beam Global(BEEM.US) With Buy Rating, Announces Target Price $1.5Market news · 18 Jul 2026 · Direct mention
  • Wells Fargo Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $70Market news · 4 Jun 2026 · Direct mention
  • Wedbush Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $65Market news · 23 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BEAM.

Sign in to join the discussion.

Scroll to Top